Optimizing enterprise data is key to precision medicine. It also helps address other industry challenges ied to cost and complexity. Here's how.
With the global pandemic, the life sciences industry experienced a surge in innovation and capability expansion to meet unprecedented challenges. Today, the industry faces a new set of challenges including inflation, talent shortages and supply chain constraints. In this paper, KPMG subject matter professionals acknowledge these challenges and discuss the trends they are observing in the market as organizations find ways to re-balance cost and growth without sacrificing innovation. Some of the steps suggested by the authors about how to re-balance cost and growth include:
Moreover, the paper provides insights into how life sciences organizations can begin to move towards rediscovering profitable growth in this time of stress for the industry.
LIfe Sciences in a Time of Stress
A reckoning in the aftermath of COVIDDownload PDF
Healthcare and Life Sciences
Transform Your Business, Streamline Operations, and Manage Risk.